Olema Pharmaceuticals, Inc.OLMANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank57
3Y CAGR+26.8%
5Y CAGR-32.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+26.8%/yr
vs +65.6%/yr prior
5Y CAGR
-32.3%/yr
Recent acceleration
Acceleration
-38.9pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $48.30M | -65.4% |
| 2024 | $139.48M | +103.5% |
| 2023 | $68.54M | +189.2% |
| 2022 | $23.70M | +71.6% |
| 2021 | $13.81M | -95.9% |
| 2020 | $338.55M | +497766.2% |
| 2019 | $68000.00 | -97.8% |
| 2018 | $3.15M | - |